A randomized controlled trial at a tertiary gynecologic oncology center in Turkey enrolled 90 women undergoing colposcopy. Participants were assigned to receive virtual reality, a podcast, or standard care during the procedure. The primary outcome was change in State-Trait Anxiety Inventory scores.
Both active interventions significantly reduced anxiety compared to standard care. The virtual reality group showed a -7.9 point change, the podcast group -10.5 points, while the control group increased by +6.5 points (p < 0.001). For pain, Visual Analog Scale scores were lowest with virtual reality (1.7) compared to podcast (3.0) and control (4.3) (p < 0.001). Patient satisfaction scores were highest with virtual reality (9.4) versus podcast (7.9) and control (4.2) (p < 0.001).
Analgesic use in the 24 hours post-procedure was lower in both intervention groups (virtual reality 46.4%, podcast 55.2%) compared to control (76.7%) (p = 0.047). Perceived Stress Scale scores showed no significant group differences. Two participants in the virtual reality group experienced mild, self-limiting adverse effects.
Key limitations include the single-center design and lack of long-term follow-up. The study did not report on serious adverse events or discontinuations. These results suggest that distraction-based strategies, particularly virtual reality, may improve the immediate procedural experience during colposcopy, but broader implementation requires further validation.
View Original Abstract ↓
PURPOSE: Colposcopy-related anxiety affects up to 80% of women, increasing pain perception and reducing satisfaction. Virtual reality has shown promise, but few studies have compared it with other active distraction methods during colposcopy. This three-arm randomized controlled trial evaluated the effectiveness of virtual reality versus podcast versus standard care in reducing anxiety and pain during colposcopy.
METHODS: Between March and June 2025, 90 women undergoing colposcopy at a tertiary gynecologic oncology center in Turkey were randomized equally to virtual reality, podcast, or standard care. Interventions began 5 min before and continued throughout the procedure. The primary outcome was change in State-Trait Anxiety Inventory scores; secondary outcomes included Visual Analog Scale pain scores, patient satisfaction, Perceived Stress Scale scores, and 24-h analgesic use.
RESULTS: Ninety participants were randomized (96.7% completion rate). In intention-to-treat analysis, both interventions reduced anxiety significantly compared with control (State-Trait Anxiety Inventory change: virtual reality -7.9, podcast -10.5, control + 6.5; p < 0.001). Virtual reality provided the strongest analgesic benefit (Visual Analog Scale 1.7 vs. 3.0 with podcast and 4.3 with control; p < 0.001) and the highest satisfaction (9.4 vs. 7.9 vs. 4.2; p < 0.001). Analgesic use was lower in the virtual reality (46.4%) and podcast (55.2%) groups compared with control (76.7%; p = 0.047). Perceived Stress Scale scores and physiological measures showed no group differences. Two participants in the virtual reality group experienced mild, self-limiting adverse effects.
CONCLUSIONS: Both virtual reality and podcasts significantly reduced colposcopy-related anxiety, with virtual reality providing superior pain control and satisfaction. Podcasts, as a rarely studied spoken-word distraction modality, represent a practical, low-cost alternative. These findings support integrating distraction-based strategies to improve patient experience during colposcopy.